~224 spots leftby Jun 2026

Telehealth Pulmonary Rehabilitation for COPD

Recruiting at13 trial locations
SP
Overseen bySurya Bhatt, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of Alabama at Birmingham
Disqualifiers: Severe heart failure, Asthma, Active cancers, others
No Placebo Group
Approved in 2 Jurisdictions

Trial Summary

What is the purpose of this trial?

The purpose of this study is to compare the efficacy and safety of a real time video telehealth pulmonary rehabilitation intervention with standard of care in patients hospitalized for an exacerbation of chronic obstructive pulmonary disease (COPD) to determine the impact on hospital readmissions and respiratory morbidity, and to investigate the cost-effectiveness of the intervention.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Video Telehealth Pulmonary Rehabilitation, Telehealth Pulmonary Rehabilitation, Virtual Pulmonary Rehabilitation, Telerehabilitation for COPD?

Research shows that telehealth pulmonary rehabilitation for COPD patients is feasible and can provide positive clinical and social benefits, making it a promising alternative to traditional in-person programs, especially when access to such programs is limited.12345

Is telehealth pulmonary rehabilitation safe for people with COPD?

Research shows that telehealth pulmonary rehabilitation is safe for people with COPD, with no major adverse events reported in studies.45678

How is the treatment 'Video Telehealth Pulmonary Rehabilitation' different from other treatments for COPD?

Video Telehealth Pulmonary Rehabilitation is unique because it allows COPD patients to participate in rehabilitation programs from home using video technology, making it more accessible and convenient compared to traditional in-person rehabilitation sessions. This approach can enhance patient participation and provide clinical and social benefits, especially for those who have limited access to conventional rehabilitation centers.12345

Research Team

SP

Surya Bhatt, MD

Principal Investigator

University of Alabama at Birmingham

Eligibility Criteria

This trial is for adults aged 40-85 hospitalized with a flare-up of COPD, willing to follow the study plan and give consent. Excluded are those with terminal illnesses, severe heart failure, cognitive issues preventing safe participation, non-English speakers, certain immunosuppressed states or active cancers, recent heart attacks or on invasive ventilation.

Inclusion Criteria

I am in the hospital for a severe COPD flare-up.
I have been diagnosed with COPD.
I am between 40 and 85 years old.
See 2 more

Exclusion Criteria

I have a terminal illness and/or am receiving hospice care.
I have severe heart failure with significant symptoms or very poor heart pump function.
I am currently receiving chemotherapy or radiation for my cancer.
See 16 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks
1 visit (in-person)

Treatment

Participants receive video telehealth pulmonary rehabilitation sessions three times a week for 12 weeks

12 weeks
36 sessions (virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 13 weeks and 52 weeks

39 weeks
Monthly phone calls, assessments at 13 and 52 weeks

Treatment Details

Interventions

  • Video Telehealth Pulmonary Rehabilitation (Behavioral Intervention)
Trial OverviewThe study tests if video telehealth pulmonary rehabilitation can reduce hospital readmissions in COPD patients compared to standard care. It will assess effectiveness and safety of this method and its cost-effectiveness.
Participant Groups
2Treatment groups
Active Control
Group I: Standard of CareActive Control1 Intervention
Participants will receive standard of care for COPD management per local guidance. In addition, they will receive 4-weekly phone calls for 13 weeks post discharge to inquire about health status and exacerbations.
Group II: Video Telehealth Pulmonary RehabilitationActive Control1 Intervention
In addition to standard of care, participants will be asked to participate in rehabilitation sessions administered at home via live videoconferencing for approximately 60 minutes a session, three times a week. A total of 36 sessions will be planned to be completed by week 13 post-discharge. Exacerbations and health status will be ascertained every 4-weeks for 13 weeks.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+
Kierstin Kennedy profile image

Kierstin Kennedy

University of Alabama at Birmingham

Chief Medical Officer since 2022

MD

S. Dawn Bulgarella profile image

S. Dawn Bulgarella

University of Alabama at Birmingham

Chief Executive Officer since 2023

BSc in Commerce and Business Administration from the University of Alabama, MS in Health Administration from the University of Alabama at Birmingham

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+
Dr. Gary H. Gibbons profile image

Dr. Gary H. Gibbons

National Heart, Lung, and Blood Institute (NHLBI)

Chief Executive Officer since 2012

MD from Harvard Medical School

Dr. James P. Kiley profile image

Dr. James P. Kiley

National Heart, Lung, and Blood Institute (NHLBI)

Chief Medical Officer since 2011

MD from University of California, San Francisco

Findings from Research

Tele-pulmonary rehabilitation has emerged as a feasible and effective alternative to traditional in-person pulmonary rehabilitation for patients with chronic obstructive pulmonary disease (COPD), especially during the COVID-19 pandemic.
A hybrid model combining both in-person and remote components may be the best approach for delivering pulmonary rehabilitation in the future, but further high-quality studies and collaboration are needed to optimize this model.
Pulmonary rehabilitation in a postcoronavirus disease 2019 world: feasibility, challenges, and solutions.Wen, J., Milne, S., Sin, DD.[2023]
Telerehabilitation for COPD patients is a safe and effective alternative to conventional pulmonary rehabilitation, showing no inferior results in improving functional exercise capacity and quality of life across ten studies involving 1492 participants.
Despite the positive outcomes, the study highlights a significant variability in telerehabilitation methods, indicating a need for a standardized approach to therapy and technology use in future implementations.
Effects of Home-Based Training with Internet Telehealth Guidance in COPD Patients Entering Pulmonary Rehabilitation: A Systematic Review.Hartman, M., Mináriková, J., Batalik, L., et al.[2023]
Telehealthcare significantly improves physical activity levels in patients with chronic obstructive pulmonary disease (COPD), with an average increase of 64.7 minutes compared to standard care, based on a systematic review of 9 studies involving 982 patients.
However, telehealthcare did not show significant differences in physical capacity or dyspnea levels, indicating that while it can enhance activity, it may not directly improve other aspects of COPD management.
Telehealthcare in COPD: a systematic review and meta-analysis on physical outcomes and dyspnea.Lundell, S., Holmner, Å., Rehn, B., et al.[2022]

References

Pulmonary rehabilitation in a postcoronavirus disease 2019 world: feasibility, challenges, and solutions. [2023]
Effects of Home-Based Training with Internet Telehealth Guidance in COPD Patients Entering Pulmonary Rehabilitation: A Systematic Review. [2023]
Telehealthcare in COPD: a systematic review and meta-analysis on physical outcomes and dyspnea. [2022]
Delivering Pulmonary Rehabilitation for Patients with Chronic Obstructive Pulmonary Disease at Home Using Telehealth: A Review of the Literature. [2020]
Telerehabilitation Programme as a Maintenance Strategy for COPD Patients: A 12-Month Randomized Clinical Trial. [2021]
The Accessibility, Feasibility, and Safety of a Standardized Community-based Tele-Pulmonary Rehab Program for Chronic Obstructive Pulmonary Disease: A 3-Year Real-World Prospective Study. [2022]
Feasibility of an online platform delivery of pulmonary rehabilitation for individuals with chronic respiratory disease. [2021]
Efficacy of respiratory tele-rehabilitation in COPD patients: Systematic review and meta-analysis. [2022]